1.Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
Wei-ru ZHANG ; Fan-fan HOU ; Jian-ping NING ; Xiao-bing YANG ; Qiang WU ; Li-jian TAO ; Ben-mei CHEN ; Hong-yan LI ; Lan CHANG
Journal of Central South University(Medical Sciences) 2006;31(5):621-628
OBJECTIVE:
To determine the association between asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, with atherosclerosis in patients with chronic kidney disease (CKD).
METHODS:
One hundred thirty-eight CKD patients were enrolled in this study. Serum levels of L-arginine, ADMA, and SDMA were measured by high-performance liquid chromatography (HPLC). Common carotid arteries intimae-medial thickness (CCA-IMT), cross-sectional calculated intimae-medial thickness (cIM area) and atherosclerotic plaque were detected by noninvasive high-resolution B-mode ultrasonography.
RESULTS:
Serum levels of ADMA and SDMA were significantly increased in CKD patients (n=138) compared with age matched healthy subjects (n=42, P<0.01). ADMA and SDMA levels increased with the progression of renal dysfunction and were negatively related to creatinine clearance (Ccr) in pre-dialysis patients (r=-0.315, P<0.05; r=-0.426, P<0.01). Serum levels of ADMA and SDMA in dialysis patients (n=74) were significantly higher than those in pre-dialysis patients (P<0.05). Patients with carotid artery plaques showed significantly higher levels of ADMA compared with those without plaques. Serum levels of ADMA closely correlated with the mean IMT (r=0.471, P<0.01) and cIM area value (r=0.430, P<0.01). These correlations remained significant even after adjusting GFR, age, gender ,and other risk factors for atherosclerosis in the multiple regression analysis.
CONCLUSION
Serum levels of ADMA increased with the progression of CKD and may play a role in the pathogenesis of accelerated atherosclerosis in CKD patients.
Adult
;
Arginine
;
analogs & derivatives
;
blood
;
Carotid Artery Diseases
;
blood
;
etiology
;
Female
;
Humans
;
Kidney Failure, Chronic
;
blood
;
complications
;
therapy
;
Male
;
Middle Aged
;
Nitric Oxide Synthase
;
antagonists & inhibitors
;
Renal Dialysis
2.The relationship between plasma leptin and nutritional status in chronic hemodialysis patients.
Ja Ryong KOO ; Ky Yong PAK ; Ken Ho KIM ; Rho Won CHUN ; Hyung Jik KIM ; Dong Wan CHAE ; Moon Gi CHOI ; Jung Woo NOH
Journal of Korean Medical Science 1999;14(5):546-551
Leptin serves an important role in suppressing appetite in mice and is known to be elevated in chronic renal failure (CRF) patients. But clinical significance of leptin as an appetite-reducing uremic toxin, remains to be determined. So we studied the relationship between plasma leptin and nutritional status in 46 chronic hemodialysis (HD) patients. Pre HD leptin was measured and divided by body mass index (BMI) to give adjusted leptin levels. KT/Vurea (K, dialyzer urea clearance; T, duration of HD; V, volume of distribution of urea), C-reactive protein (CRP), plasma insulin and nutritional parameters such as serum albumin, normalized protein catabolic rate (nPCR), subjective global assessment (SGA), BMI and mid-arm muscle circumference (MAMC) were also measured. Mean plasma leptin levels were 8.13+/-2.91 ng/mL (male 3.15+/-0.70; female 14.07+/-6.14, p<0.05). Adjusted leptin levels were positively correlated with nPCR (male r=0.47, p<0.05; female r=0.46, p<0.05), SGA (male r=0.43, p<0.05; female r=0.51, p<0.05) and MAMC (male r=0.60, p<0.005; female r=0.61, p<0.05). They did not correlate with KT/Vurea, serum albumin, hematocrit, bicarbonate, insulin and CRP. Presence of DM and erythropoietin therapy had no effect on leptin levels. These results suggest that leptin is a marker of good nutritional status rather than a cause of protein energy malnutrition in chronic HD patients.
Adult
;
Biological Markers/blood
;
Cross-Sectional Studies
;
Female
;
Human
;
Kidney Failure, Chronic/therapy
;
Kidney Failure, Chronic/complications
;
Kidney Failure, Chronic/blood*
;
Leptin/blood*
;
Male
;
Middle Age
;
Nutrition Disorders/etiology
;
Nutrition Disorders/diagnosis
;
Nutritional Status*
;
Obesity/metabolism
;
Obesity/etiology
;
Renal Dialysis*/adverse effects
;
Sex Factors
3.Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction.
Jae Seok KIM ; Jae Won YANG ; Moon Hee CHAI ; Jun Young LEE ; Hyeoncheol PARK ; Youngsub KIM ; Seung Ok CHOI ; Byoung Geun HAN
Yonsei Medical Journal 2015;56(4):976-980
PURPOSE: Copeptin has been considered as a useful marker for diagnosis and prediction of prognosis in heart diseases. However, copeptin has not been investigated sufficiently in hemodialysis patients. This study aimed to investigate the general features of copeptin in hemodialysis and to examine the usefulness of copeptin in hemodialysis patients with left ventricular dysfunction (LV dysfunction). MATERIALS AND METHODS: This study included 41 patients on regular hemodialysis. Routine laboratory data and peptides such as the N-terminal of the prohormone brain natriuretic peptide and copeptin were measured on the day of hemodialysis. Body fluid volume was estimated by bioimpedance spectroscopy, and the E/Ea ratio was estimated by echocardiography. RESULTS: Copeptin increased to 171.4 pg/mL before hemodialysis. The copeptin had a positive correlation with pre-dialysis body fluid volume (r=0.314; p=0.04). The copeptin level decreased along with body fluid volume and plasma osmolality during hemodialysis. The copeptin increased in the patients with LV dysfunction more than in those with normal LV function (218.7 pg/mL vs. 77.6 pg/mL; p=0.01). Receiver operating characteristic curve analysis showed that copeptin had a diagnostic value in the hemodialysis patients with LV dysfunction (area under curve 0.737; p=0.02) and that the cut-off value was 125.48 pg/mL (sensitivity 0.7, specificity 0.8, positive predictive value 0.9, negative predictive value 0.6). CONCLUSION: Copeptin increases in hemodialysis patients and is higher in patients with LV dysfunction. We believe that copeptin can be a useful marker for the diagnosis of LV dysfunction in hemodialysis patients.
Adult
;
Aged
;
Biomarkers/blood
;
Echocardiography
;
Female
;
Glycopeptides/*blood
;
Humans
;
Kidney Failure, Chronic/*blood/complications/therapy
;
Male
;
Middle Aged
;
Natriuretic Peptide, Brain/blood
;
Predictive Value of Tests
;
Prognosis
;
ROC Curve
;
Renal Dialysis/*adverse effects
;
Sensitivity and Specificity
;
Ventricular Dysfunction, Left/*blood/complications/*physiopathology
4.Five cases of cytomegalovirus infection detected by in situ hybridization and antigenemia assay.
Jin Hong YOO ; Jong Young CHOI ; Yang Ree KIM ; Yeong Jin CHOI ; Sang In SHIM ; Hak Ki KIM ; Chul Woo YANG ; Yong Soo KIM ; Chi Wha HAHN ; Wan Shik SHIN ; Chong Won PARK ; Moon Won KANG ; Choon Choo KIM ; Byung Kee BANG ; Dong Jip KIM
Journal of Korean Medical Science 1994;9(6):507-512
We report five cases of cytomegalovirus infection in immunocompromised patients which were detected by either cytomegalovirus antigenemia assay or in situ hybridization. Four cases had leukemia and the other had chronic renal failure. All the three BMT recipients suffered from GvHD. Interestingly, there was an unique case of CMV disease without a history of BMT, which reminded us that CMV could attack immunocompromised patients who had not undergone transplantation, too. Four out of five cases died. We think that cytomegalovirus infection or disease should not be regarded as a minor problem in post-transplantation infection in Korea.
Adolescent
;
Adult
;
Antigens, Viral/*blood
;
*Bone Marrow Transplantation
;
Case Report
;
Cytomegalovirus/*immunology
;
Cytomegalovirus Infections/complications/*diagnosis
;
Fatal Outcome
;
Graft vs Host Disease/complications
;
Human
;
Immunocompromised Host
;
In Situ Hybridization
;
Kidney Failure, Chronic/complications
;
Kidney Transplantation
;
Leukemia/*complications/therapy
;
Leukemia, Lymphocytic, Acute, L2/complications/therapy
;
Leukemia, Myelocytic, Acute/complications/therapy
;
Leukemia, Myeloid, Chronic/complications/therapy
;
Male
;
Viremia/*diagnosis
5.Relationship between the Serum Parathyroid Hormone and Magnesium Levels in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients using Low-magnesium Peritoneal Dialysate.
Min Seok CHO ; Kyun Sang LEE ; Youn Kyoung LEE ; Seong Kwon MA ; Jeong Hee KO ; Soo Wan KIM ; Nam Ho KIM ; Ki Chul CHOI
The Korean Journal of Internal Medicine 2002;17(2):114-121
BACKGROUND: Patients on continuous ambulatory peritoneal dialysis (CAPD) have increased risk of low-turnover bone disease and relative hypoparathyroidism. Recently, it has been believed that magnesium plays an important role in regulating secretion of parathyroid hormone (PTH). The aim of this study was to evaluate the relationship between serum PTH and serum magnesium as a factor increasing the frequency of relative hypoparathyroidism. METHODS: We analyzed the data of 56 patients who had been on CAPD for more than 6 months without any significant problems. No patient had been previously treated with vitamin D or aluminum hydroxide. The patients had used peritoneal dialysate with the magnesium concentration of 0.5 mEq/L. Biochemical parameters, such as BUN, creatinine, alkaline phosphatase bony isoenzyme, total protein, albumin, total calcium, ionized calcium and intact parathyroid hormone level were measured. RESULTS: The mean serum magnesium level was 1.99 +/- 0.36 mEq/L. Among total 56 patients, 15 patients (26.8%) showed hypermagnesemia (serum magnesium > 2.2 mEq/L) and 5 patients (8.9%) showed hypomagnesemia (serum magnesium < 1.6 mEq/L). Among all 56 patients, serum iPTH (intact PTH) level was not correlated with serum magnesium level. However, it was inversely correlated with serum total calcium and ionized calcium levels, respectively (r=-0.365, p=0.006; r=-0.515 p < 0.001). Among 49 patients whose serum iPTH level was less than 300 pg/mL, serum iPTH level was inversely correlated with serum magnesium level (r=-0.295, p=0.039) and inversely correlated with serum total calcium and ionized calcium levels, respectively (r=-0.546, p < 0.001; r=-0.572 p < 0.001). Among 49 patients whose serum iPTH level was less than 300 pg/mL, lower iPTH group (serum iPTH < 120 pg/mL) showed higher serum magnesium level (p=0.037), higher serum total calcium level (p < 0.001) and lower bone isoenzyme of alkaline phosphatase level (p < 0.001) than those of higher iPTH group (120 pg/mL
6.Ministry of Health Clinical Practice Guidelines: Lipids.
E Shyong TAI ; Boon Lock CHIA ; Amber Carla BASTIAN ; Terrance CHUA ; Sally Chih Wei HO ; Teck Siew KOH ; Lip Ping LOW ; Jeannie S TEY ; Kian Keong POH ; Chee Eng TAN ; Peter TING ; Tat Yean THAM ; Sue-Anne TOH ; Rob M van DAM
Singapore medical journal 2017;58(3):155-166
The Ministry of Health (MOH) has updated the Clinical Practice Guidelines on Lipids to provide doctors and patients in Singapore with evidence-based treatment for lipids. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH Clinical Practice Guidelines on Lipids, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html.
Adult
;
Cardiovascular Diseases
;
complications
;
therapy
;
Child
;
Coronary Artery Disease
;
complications
;
therapy
;
Decision Support Systems, Clinical
;
Dyslipidemias
;
blood
;
complications
;
therapy
;
Evidence-Based Medicine
;
Female
;
Humans
;
Kidney Failure, Chronic
;
complications
;
therapy
;
Life Style
;
Lipids
;
blood
;
Lipoproteins, LDL
;
blood
;
Male
;
Practice Guidelines as Topic
;
Pregnancy
;
Pregnancy Complications
;
Risk Assessment
;
Risk Factors
;
Singapore
7.Intestinal Paragonimiasis with Colonic Ulcer and Hematochezia in An Elderly Taiwanese Woman.
Chung Te LIU ; Yen Cheng CHEN ; Tso Hsiao CHEN ; Ursula BARGHOUTH ; Chia Kwung FAN
The Korean Journal of Parasitology 2012;50(4):349-352
A 94-year-old female with end-stage renal disease presents with fever, fatigue, and hematochezia. She had previously resided in Hunan Province, China, and Myanmar, and she immigrated to Taiwan 30 years ago. Colonoscopy revealed a colonic ulcer. Biopsy of the colonic ulcer showed ulceration of the colonic mucosa, and many Paragonimus westermani-like eggs were noted. Serum IgG antibody levels showed strong reactivity with P. westermani excretory-secretory antigens by ELISA. Intestinal paragonimiasis was thus diagnosed according to the morphology of the eggs and serologic finding. After treatment with praziquantel, hematochezia resolved. The present case illustrates the extreme manifestations encountered in severe intestinal paragonimiasis.
Aged, 80 and over
;
Animals
;
Anthelmintics/therapeutic use
;
Antibodies, Helminth/blood
;
Antigens, Helminth/immunology
;
Colonic Diseases/complications/drug therapy/*pathology
;
Colonoscopy
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Gastrointestinal Hemorrhage/complications/drug therapy/*pathology
;
Humans
;
Intestinal Diseases, Parasitic/complications/drug therapy/parasitology/*pathology
;
Kidney Failure, Chronic/complications
;
Paragonimiasis/complications/drug therapy/parasitology/*pathology
;
Paragonimus westermani/*immunology
;
Praziquantel/therapeutic use
;
Taiwan
;
Ulcer/complications/drug therapy/*pathology
8.Carpal Tunnel Syndrome and Peripheral Polyneuropathy in Patients with End Stage Kidney Disease.
Hee Kyu KWON ; Sung Bom PYUN ; Won Yong CHO ; Chang Su BOO
Journal of Korean Medical Science 2011;26(9):1227-1230
This study was designed to identify the causes of the development of carpal tunnel syndrome (CTS) associated with end stage kidney disease (ESKD). A total of 112 patients with ESKD, 64 on hemodialysis (HD) and 48 on peritoneal dialysis (PD), were enrolled. The duration of ESKD and dialysis, the site of the arteriovenous (A-V) fistula for HD, laboratory data such as blood urea nitrogen, creatinine, and beta-2-microglobulin were determined. Clinical evaluation of CTS and electrophysiological studies for the diagnosis of CTS and peripheral neuropathy were performed. The electrophysiological studies showed that the frequency of CTS was not different in the HD and PD groups (P = 0.823) and the frequency of CTS was not different in the limb with the A-V fistula compared to the contralateral limb (P = 0.816). The frequency of HD and PD were not related to beta-2-microglobulin levels, an indicator of amyloidosis. The frequency of CTS did not increase as the severity of the peripheral neuropathy and the duration of ESKD and dialysis increased (P = 0.307). The results of this study do not support that microglobulin induced amyloidosis or placement of an A-V fistula are associated with an increase in CTS.
Adult
;
Aged
;
Amyloidosis/complications
;
Arteriovenous Fistula/complications
;
Blood Urea Nitrogen
;
Carpal Tunnel Syndrome/*complications/*diagnosis
;
Creatinine/blood
;
Electrophysiological Phenomena
;
Female
;
Humans
;
Kidney Failure, Chronic/*complications/*therapy
;
Male
;
Middle Aged
;
Peritoneal Dialysis/adverse effects
;
Polyneuropathies/*complications/*diagnosis
;
Renal Dialysis/adverse effects
;
beta 2-Microglobulin/blood
9.Effect of Shenshuai Yangzhen capsule on remnant renal tissue following 5/6 nephrectomy in malnutrition rats with chronic renal failure.
Yu-ming LI ; Lian-bo WEI ; Cong DENG
Journal of Southern Medical University 2007;27(6):787-791
OBJECTIVETo investigate effects of Shenshuai Yangzhen capsule, a preparation of traditional Chinese medicine, on remnant renal tissue following nephrectomy in malnutrition rats with chronic renal failure.
METHODSSD rats were subjected to 5/6 nephrectomy and fed 4% casein diet to induce chronic renal failure (CRF), and their blood urea nitrogen (BUN), serum creatinine (Scr), serum albumin (ALB), hemoglobin (Hb), 24-hour urineprotein (24-h Upro) and body weight were measured. Upon the onset of malnutrition, the rats were randomized into CRF control group (CC), ketosteril group (KT), and Shenshuai Yangzhen group (SSYZ), with also a normal control group (NC). After 4 weeks of treatment as indicated, the remnant nephrotic tissue was examined under optical and electron microscopes and by immunofluorescence assay.
RESULTSMalnutrition occurred in the CRF rats at the end of the 10th weeks after the operation. Compared with those in CC group, the plasma BUN, SCr and 24-h Upro levels in SSYZ group were significantly lower with substantially elevated plasma ALB and Hb. The pathological changes of SSYZ group was significantly improved after treatment with Shenshuai Yangzhen capsule.
CONCLUSIONShenshuai Yangzhen capsule can improve malnutrition and reduce renal damage in rats with renal insufficiency.
Animals ; Blood Urea Nitrogen ; Capsules ; Creatinine ; blood ; Drugs, Chinese Herbal ; pharmacology ; Kidney ; drug effects ; surgery ; ultrastructure ; Kidney Failure, Chronic ; blood ; complications ; drug therapy ; Male ; Malnutrition ; complications ; drug therapy ; Microscopy, Electron ; Nephrectomy ; methods ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Serum Albumin ; analysis ; Treatment Outcome
10.Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus.
Long-Kai PENG ; Xu-Biao XIE ; Feng-Hua PENG ; Yu WANG ; Yi JIANG ; Gong-Bin LAN ; Chun-Hua FANG ; Man-Hua NIE
Journal of Central South University(Medical Sciences) 2007;32(1):59-62
OBJECTIVE:
To investigate the feasibility and safety of substituting tacrolimus(FK506) for cyclosporin A(CsA) on delaying the pace of renal dysfunction in patients with biopsy-proven chronic allograft nephropathy(CAN).
METHODS:
Seventy-three renal transplantation patients with CAN proved by allograft biopsy were collected in this study. Patients were randomly divided into 2 groups. Patients were either converted to FK506(FK506 group, n=43) or remained on their initial CsA-based immunosuppression(CsA group, n=30). The clinical data at study entry and after 12 months including blood urea nitrogen(BUN), serum creatinine(SCr), glomerular filtration rate(GFR), 24-hour urine protein excretion, serum total cholesterol(TC), triglyceride(TG), low density lipoprotein(LDL) and the side effects of calcineurin inhibitors were monitored during a follow-up of over 12 months.
RESULTS:
Twelve months later, the level of SCr was statistically reduced and GFR levels were obviously elevated in the FK506 group as compared with CsA group [(194.8+/-42.5)micromol/L vs. (245.4+/-52.8)micromol/L and (50.14+/-3.92)mL/(min.1.73 m(2)) vs. (40.58+/-2.49)mL/(min.1.73 m2), P<0.01]. Quantity of 24-hour urine protein excretion in the FK506 group was (2.0+/-0.5)g which is significantly lower than (3.9+/-0.7)g in the CsA group(P<0.01). TC, TG, and LDL levels remained unchanged in the CsA group, while those were statistically reduced in the FK506 group respectively [(5.19+/-0.73)mmol/L vs. (6.94+/-1.37)mmol/L, (1.86+/-0.84)mmol/L vs. (3.14+/-1.38)mmol/L, (3.03+/-0.71)mmol/L vs. (3.82+/-0.89)mmol/L, P<0.01]. Tremor obviously increased (P<0.01) and hypertension obviously decreased (P<0.05) in the FK506 group compared with the CsA group.
CONCLUSION
FK506 treatment can greatly improve the proteinuria and hyperlipidemia. Conversion from CsA to FK506 is an effective and safe alternative therapy for delaying the progression of renal dysfunction induced by CAN.
Adult
;
Aged
;
Cholesterol
;
blood
;
Creatinine
;
blood
;
Cyclosporine
;
therapeutic use
;
Female
;
Follow-Up Studies
;
Glomerular Filtration Rate
;
Graft Rejection
;
complications
;
Humans
;
Immunosuppressive Agents
;
therapeutic use
;
Kidney Failure, Chronic
;
blood
;
drug therapy
;
etiology
;
Kidney Transplantation
;
adverse effects
;
Lipoproteins, LDL
;
blood
;
Male
;
Middle Aged
;
Tacrolimus
;
therapeutic use
;
Treatment Outcome
;
Triglycerides
;
blood